Aptose Biosciences
Why Robinhood?
You can watch APTOF and buy or sell other stocks, ETFs, and their options commission-free!About APTOF
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.
APTOF Key Statistics
Stock Snapshot
The current Aptose Biosciences(APTOF) stock price is $1.57, with a market capitalization of 4.03M. The stock trades at a price-to-earnings (P/E) ratio of -0.15.
During the trading session on 2026-06-08, Aptose Biosciences(APTOF) shares reached a daily high of $1.57 and a low of $1.54. At a current price of $1.57, the stock is +1.9% higher than the low and still 0.0% under the high.
Trading volume for Aptose Biosciences(APTOF) stock has reached 809, versus its average volume of 512.11.
Over the past 52 weeks, Aptose Biosciences(APTOF) stock has traded between a high of $1.85 and a low of $0.64.
Over the past 52 weeks, Aptose Biosciences(APTOF) stock has traded between a high of $1.85 and a low of $0.64.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.